BI-10773 (Empagliflozin) Combination Database
Please select the combination compounds (Multiple selections allowed)
Please select a combination compound first
Jump to
- BI-10773 (Empagliflozin) Mechanism of Action: SGLT2 Inhibition in Cardiomyocytes Research
- BI-10773 (Empagliflozin) Clinical Trials
- BI-10773 (Empagliflozin) Working Concentration | Cell Culture | Treatment
- BI-10773 (Empagliflozin) Solubility in DMSO
- BI-10773 (Empagliflozin) Stock Solution
- BI-10773 (Empagliflozin) Storage
- BI-10773 (Empagliflozin) Stability
- BI-10773 (Empagliflozin) Molecular Weight
- BI-10773 (Empagliflozin) SMILES
- BI-10773 (Empagliflozin) CAS Number
- BI-10773 (Empagliflozin) Chemical Structure (2D and 3D)
- BI-10773 (Empagliflozin) IC50 for Cell-based and Cell-free Assays
- BI-10773 (Empagliflozin) Sigma (SML4200)? Try a better option.
- BI-10773 (Empagliflozin) MedChemExpress (HY-15409)? Try a better option.
- BI-10773 (Empagliflozin) Cayman (17375)? Try a better option.
- BI-10773 (Empagliflozin) APExBIO (A4601)? Try a better option.
- BI-10773 (Empagliflozin) Axonmedchem (Axon 3367)? Try a better option.
- BI-10773 (Empagliflozin) SDS｜MSDS